BCR-ABL SIGNALING A new STATus in CML

被引：0

作者：

Fabbro, Doriano ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Basel, Switzerland

来源：

NATURE CHEMICAL BIOLOGY | 2012年 / 8卷 / 03期

关键词：

CHRONIC MYELOID-LEUKEMIA; BCR/ABL;

D O I：

10.1038/nchembio.900

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：228 / 229

页数：2

共 50 条

[21] Multidomain Targeting of Bcr-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML [J].

Miller, Geoffrey D. ;

Woessner, David W. ;

Sirch, Monika J. ;

Lim, Carol S. .

MOLECULAR PHARMACEUTICS, 2013, 10 (09) :3475-3483

[22] IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation [J].

Massimino, Michele ;

Consoli, Maria Letizia ;

Mesuraca, Maria ;

Stagno, Fabio ;

Tirro, Elena ;

Stella, Stefania ;

Pennisi, Maria Stella ;

Romano, Chiara ;

Buffa, Pietro ;

Bond, Heather M. ;

Morrone, Giovanni ;

Sciacca, Laura ;

Di Raimondo, Francesco ;

Manzella, Livia ;

Vigneri, Paolo .

CARCINOGENESIS, 2014, 35 (05) :1132-1143

[23] Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML [J].

Bakshi, Sonal R. ;

Patel, Beena P. ;

Brahmbhatt, Manisha M. ;

Trivedi, Pina J. ;

Gajjar, Sarju B. ;

Iyer, Ramesh R. ;

Parikh, Esha H. ;

Shukla, Shilin N. ;

Shah, Pankaj M. .

CANCER GENETICS AND CYTOGENETICS, 2009, 189 (02) :142-143

[24] New Insights Into Small-Molecule Inhibitors of Bcr-Abl [J].

Schenone, S. ;

Bruno, O. ;

Radi, M. ;

Botta, M. .

MEDICINAL RESEARCH REVIEWS, 2011, 31 (01) :1-41

[25] Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML [J].

Agarwal, Anupriya ;

Fleischman, Angela G. ;

Petersen, Curtis L. ;

MacKenzie, Ryan ;

Luty, Samuel ;

Loriaux, Marc ;

Druker, Brian J. ;

Woltjer, Randall L. ;

Deininger, Michael W. .

BLOOD, 2012, 120 (13) :2658-2668

[26] ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [J].

Ferreira, A. F. ;

Moura, L. G. ;

Tojal, I. ;

Ambrosio, L. ;

Pinto-Simoes, B. ;

Hamerschlak, N. ;

Calin, G. A. ;

Ivan, C. ;

Covas, D. T. ;

Kashima, S. ;

Castro, F. A. .

BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (1-2) :47-55

[27] Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone [J].

Malik, Vidhi ;

Radhakrishnan, Navaneethan ;

Kaul, Sunil C. ;

Wadhwa, Renu ;

Sundar, Durai .

BIOMOLECULES, 2022, 12 (02)

[28] Bcr-Abl induces autocrine IGF-1 signaling [J].

A Lakshmikuttyamma ;

E Pastural ;

N Takahashi ;

K Sawada ;

D P Sheridan ;

J F DeCoteau ;

C R Geyer .

Oncogene, 2008, 27 :3831-3844

[29] Bcr-Abl induces autocrine IGF-1 signaling [J].

Lakshmikuttyamma, A. ;

Pastural, E. ;

Takahashi, N. ;

Sawada, K. ;

Sheridan, D. P. ;

DeCoteau, J. F. ;

Geyer, C. R. .

ONCOGENE, 2008, 27 (27) :3831-3844

[30] Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia [J].

Samanta, A. ;

Perazzona, B. ;

Chakraborty, S. ;

Sun, X. ;

Modi, H. ;

Bhatia, R. ;

Priebe, W. ;

Arlinghaus, R. .

LEUKEMIA, 2011, 25 (03) :463-472

← 1 2 3 4 5 →